A citation-based method for searching scientific literature

Heming Guo, Chen Fang, Yun Huang, Yufang Pei, Linqi Chen, Ji Hu. Diabetes Res Clin Pract 2016
Times Cited: 34







List of co-cited articles
285 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes.
Halis Kaan Akturk, Dominique Giordano, Anagha Champakanath, Scott Brackett, Satish Garg, Janet Snell-Bergeon. Diabetes Obes Metab 2020
20
5

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.
Rayhan A Lal, Marina Basina, David M Maahs, Korey Hood, Bruce Buckingham, Darrell M Wilson. Diabetes Care 2019
66
2

Properties of pramlintide and insulin upon mixing.
Christian Weyer, Mark S Fineman, Susan Strobel, Larry Shen, Joann Data, Orville G Kolterman, Mario F Sylvestri. Am J Health Syst Pharm 2005
28
3

Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Ahmad Haidar, Rémi Rabasa-Lhoret, Laurent Legault, Leif E Lovblom, Rohan Rakheja, Virginie Messier, Émilie D'Aoust, C Marcelo Falappa, Tara Justice, Andrej Orszag,[...]. J Clin Endocrinol Metab 2016
50
2

Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
14
7

A bihormonal closed-loop artificial pancreas for type 1 diabetes.
Firas H El-Khatib, Steven J Russell, David M Nathan, Robert G Sutherlin, Edward R Damiano. Sci Transl Med 2010
231
2

Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
Torben Biester, Ido Muller, Thekla von dem Berge, Eran Atlas, Revital Nimri, Moshe Phillip, Tadej Battelino, Natasa Bratina, Klemen Dovc, Markus F Scheerer,[...]. Diabetes Obes Metab 2021
7
14


Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Steven J Russell, Mallory A Hillard, Courtney Balliro, Kendra L Magyar, Rajendranath Selagamsetty, Manasi Sinha, Kerry Grennan, Debbie Mondesir, Laya Ekhlaspour, Hui Zheng,[...]. Lancet Diabetes Endocrinol 2016
109
2

Type 2 diabetes--therapy with dipeptidyl peptidase IV inhibitors.
Hans-Ulrich Demuth, Christopher H S McIntosh, Raymond A Pederson. Biochim Biophys Acta 2005
124
2

Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours.
Arianne C van Bon, Yoeri M Luijf, Rob Koebrugge, Robin Koops, Joost B L Hoekstra, J Hans DeVries. Diabetes Technol Ther 2014
57
2

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Ahmad Haidar, Laurent Legault, Maryse Dallaire, Ammar Alkhateeb, Adèle Coriati, Virginie Messier, Peiyao Cheng, Maude Millette, Benoit Boulet, Rémi Rabasa-Lhoret. CMAJ 2013
105
2


Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.
Jessica R Castle, Joseph El Youssef, Parkash A Bakhtiani, Yu Cai, Jade M Stobbe, Deborah Branigan, Katrina Ramsey, Peter Jacobs, Ravi Reddy, Mark Woods,[...]. Diabetes Care 2015
22
4

ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes.
Grit Andersen, Grégory Meiffren, Susanne Famulla, Tim Heise, Aymeric Ranson, Cyril Seroussi, Rosy Eloy, Martin Gaudier, Richard Charvet, You-Ping Chan,[...]. Diabetes Obes Metab 2021
3
33

Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study.
Bruce W Bode, Eda Cengiz, R Paul Wadwa, Phillip Banks, Thomas Danne, Jake A Kushner, Darren K McGuire, Anne L Peters, Paul Strumph, Sangeeta Sawhney. Diabetes Technol Ther 2021
2
50

Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System.
Liana Hsu, Bruce Buckingham, Marina Basina, Laya Ekhlaspour, Rie von Eyben, Justin Wang, Rayhan A Lal. Diabetes Technol Ther 2021
7
14

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Ahmad Haidar, Laurent Legault, Laurence Matteau-Pelletier, Virginie Messier, Maryse Dallaire, Martin Ladouceur, Rémi Rabasa-Lhoret. Lancet Diabetes Endocrinol 2015
77
2

Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.
Jordan E Pinsker, Lars Müller, Alexandra Constantin, Scott Leas, Michelle Manning, Molly McElwee Malloy, Harsimran Singh, Steph Habif. Diabetes Technol Ther 2021
19
5

Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Leah M Wilson, Peter G Jacobs, Katrina L Ramsey, Navid Resalat, Ravi Reddy, Deborah Branigan, Joseph Leitschuh, Virginia Gabo, Florian Guillot, Brian Senf,[...]. Diabetes Care 2020
9
11

Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
Charlotte K Boughton, Sara Hartnell, Hood Thabit, Tina Poettler, David Herzig, Malgorzata E Wilinska, Nicole L Ashcroft, Judy Sibayan, Nathan Cohen, Peter Calhoun,[...]. Diabetes Obes Metab 2021
6
16

Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
Alexander Abitbol, Remi Rabasa-Lhoret, Virginie Messier, Laurent Legault, Mohamad Smaoui, Nathan Cohen, Ahmad Haidar. Diabetes Technol Ther 2018
15
6

Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.
Melanie A Jackson, Nicholas Caputo, Jessica R Castle, Larry L David, Charles T Roberts, W Kenneth Ward. Curr Diab Rep 2012
24
4

Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.
Per-Henrik Groop, Paresh Dandona, Moshe Phillip, Pieter Gillard, Steven Edelman, Johan Jendle, John Xu, Markus F Scheerer, Fredrik Thoren, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2020
8
12

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Pablo Aschner, Mark S Kipnes, Jared K Lunceford, Matilde Sanchez, Carolyn Mickel, Debora E Williams-Herman. Diabetes Care 2006
634
2


Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.
Joseph El Youssef, Jessica R Castle, Parkash A Bakhtiani, Ahmad Haidar, Deborah L Branigan, Matthew Breen, W Kenneth Ward. Diabetes Care 2014
33
3

Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
Helga Blauw, A Joannet Onvlee, Michel Klaassen, Arianne C van Bon, J Hans DeVries. Diabetes Care 2021
6
16

Stabilized glucagon formulation for bihormonal pump use.
Solomon S Steiner, Ming Li, Robert Hauser, Roderike Pohl. J Diabetes Sci Technol 2010
26
3

Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Ahmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, Nancy Cardinez, Andrej Orszag, C Marcelo Falappa, Nikita Gouchie-Provencher, Michael A Tsoukas, Anas El Fathi, Jennifer Rene,[...]. Diabetes Obes Metab 2021
4
25

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
Steven J Russell, Firas H El-Khatib, Manasi Sinha, Kendra L Magyar, Katherine McKeon, Laura G Goergen, Courtney Balliro, Mallory A Hillard, David M Nathan, Edward R Damiano. N Engl J Med 2014
336
2

Factors influencing the effectiveness of glucagon for preventing hypoglycemia.
Jessica R Castle, Julia M Engle, Joseph El Youssef, Ryan G Massoud, W Kenneth Ward. J Diabetes Sci Technol 2010
33
3

Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors.
Reema Abu Khalaf, Dima Sabbah, Eveen Al-Shalabi, Iyad Al-Sheikh, Ghadeer Albadawi, Ghassan Abu Sheikha. Curr Comput Aided Drug Des 2018
3
33

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.
Jon M Sutton, David E Clark, Stephen J Dunsdon, Garry Fenton, Amanda Fillmore, Neil V Harris, Chris Higgs, Chris A Hurley, Sussie L Krintel, Robert E MacKenzie,[...]. Bioorg Med Chem Lett 2012
34
2

Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus.
S O Kuranov, I P Tsypysheva, M V Khvostov, Liana F Zainullina, S S Borisevich, Yu V Vakhitova, O A Luzina, N F Salakhutdinov. Bioorg Med Chem 2018
10
10

Phenanthridine Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Design, Synthesis and Biological Evaluation.
Reema Abu Khalaf, Shorooq Alqazaqi, Maram Aburezeq, Dima Sabbah, Ghadeer Albadawi, Ghassan Abu Sheikha. Curr Comput Aided Drug Des 2020
1
100

Linagliptin: from bench to bedside.
John Doupis. Drug Des Devel Ther 2014
15
6


Identification of novel DPP-IV inhibitory peptides from Atlantic salmon (Salmo salar) skin.
Ritian Jin, Xiangyu Teng, Jiaqi Shang, Dangfeng Wang, Ning Liu. Food Res Int 2020
15
6


DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
178
2





Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated in silico approaches.
Shweta Sharma, Shubham Srivastava, Apeksha Shrivastava, Ruchi Malik, Faisal Almalki, Khalid Saifullah, Mohammad Mumtaz Alam, Mohammad Shaqiquzzaman, Shakir Ali, Mymoona Akhter. J Biomol Struct Dyn 2020
2
50

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
Richard A Friesner, Jay L Banks, Robert B Murphy, Thomas A Halgren, Jasna J Klicic, Daniel T Mainz, Matthew P Repasky, Eric H Knoll, Mee Shelley, Jason K Perry,[...]. J Med Chem 2004
2

Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo.
Fenfen Yan, Na Li, Yingxue Yue, Chengfeng Wang, Li Zhao, Smith Etareri Evivie, Bailiang Li, Guicheng Huo. Front Microbiol 2020
12
8


Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
Deyan Wu, Fangfang Jin, Weiqiang Lu, Jin Zhu, Cui Li, Wei Wang, Yun Tang, Hualiang Jiang, Jin Huang, Guixia Liu,[...]. Chem Biol Drug Des 2012
11
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.